- BioHarvest Sciences (BHSC) has appointed Steven Lehrer as its newest advisory board member, effective immediately
- He brings 40 years of experience in life science-based businesses to the company
- Mr. Lehrer provides strategy and implementation advice on various topics
- BioHarvest Sciences is a fast-growing biotech firm that has developed a patented bio-cell growth platform technology
- Shares in BioHarvest Sciences Inc. (BHC) are steady, trading at $0.39 per share
BioHarvest Sciences (BHSC) has appointed Steven Lehrer as its newest advisory board member, effective immediately.
Steven brings 40 years of experience in life science-based businesses to the company, including leading the development of several biopharmaceutical companies.
“I am excited to join the board of advisors of BioHarvest,” said Mr. Lehrer. “I strongly believe in the potential of the proprietary BioFarming technology to make a significant impact on multiple verticals of the life science-based businesses.”
He currently sits on the board of directors of two life science companies and is a member of the University of Maryland’s Bioengineering Department Advisory Board.
Mr. Lehrer provides strategy and implementation advice on various topics, including commercial efforts through operations, business development, product development, portfolio planning, and establishing international operations.
Ilan Sobel, CEO of BioHarvest, commented on Mr. Lehrer’s appointment.
“At this critical phase of the company’s growth,” said Mr. Sobel, “Steven’s experience and involvement will play an important role in the company’s quest to become a biotech leader.”
BioHarvest Sciences is a fast-growing biotech firm that has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself.
BioHarvest is currently focused on nutraceuticals and the medicinal cannabis markets.
Shares in BioHarvest Sciences Inc. (BHC) are steady, trading at $0.39 per share as of 1:28 pm ET.
